Tag: FDA inspections
Chinese Generic Production: Manufacturing and Quality Concerns
China produces 80% of the world's active pharmaceutical ingredients, but quality concerns persist. FDA inspections reveal high failure rates, data integrity issues, and supply chain risks that threaten global drug safety.
Read MoreRecent News
